Alto Neuroscience Revenue and Competitors

Location

#181

Growjo Ranking

Analytics

Industry

Estimated Revenue & Valuation

  • Alto Neuroscience's estimated annual revenue is currently $8.6M per year.(i)
  • Alto Neuroscience's estimated revenue per employee is $126,000

Employee Data

  • Alto Neuroscience has 68 Employees.(i)
  • Alto Neuroscience grew their employee count by 39% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.4M17N/AN/AN/A
#2
$0.4M6-45%N/AN/A
#3
$11.6M8343%N/AN/A
#4
$78.4M4410%$6.8MN/A
#5
$12.2M87-13%N/AN/A
#6
$68.3M38432%$131.5MN/A
#7
$1.3M16-24%N/AN/A
#8
$0.1M2-82%N/AN/A
#9
$0.6M9N/AN/AN/A
#10
$2.6M27N/AN/AN/A
Add Company

Alto Neuroscience is a private company headquartered in Los Altos, CA. Alto is developing a new generation of biomarker-based diagnostic tests and personalized treatments for use in mental health, based on a platform built from data aggregated at scale and proprietary artificial intelligence analysis tools. The team combines world-leading neuroscientists and business executives with experience commercializing products for the brain.

keywords:N/A

N/A

Total Funding

68

Number of Employees

$8.6M

Revenue (est)

39%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Alto Neuroscience News

2022-04-17 - Movers & Shakers, April 15: Spruce, Nautilus, Alto, Ikena ...

Alto Neuroscience: Mikael Eliasson was named chief operating officer. Prior to joining Alto, Eliasson led global teams at Genentech/Roche...

2022-04-13 - Industry Veteran Mikael Eliasson, M.D., Ph.D., Joins Alto ...

D., Joins Alto Neuroscience as Chief Operating Officer. -- Dr. Eliasson brings two decades of global biotechnology experience as a leader in...

2022-03-22 - Precision Medicine for Mental Illness

In December 2021, Alto Neuroscience partnered with Cerebral, an online mental health provider that offers counseling, therapy, medication...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11M68-8%N/A
#2
$7.5M6919%N/A
#3
$9.5M706%N/A
#4
$8.7M74N/AN/A
#5
$11.3M7844%N/A